|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
New Jersey Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New JerseyLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Celldex Therapeutics, Inc.. Research
| | | Phone: | (908) 454-7120 | Fax: | (908) 454-1911 | Year Established: | 2003 | Employees: | 60 | Ticker: | CLDX | Exchange: | NASDAQ | Main Contact: | Ronald A. Pepin, Ph.D., Senior VP & CBO | | Other Contacts: | Richard Wright, Ph.D., Senior VP & CCO Sarah Cavanaugh, Senior VP, Corporate Affairs & Administration Tibor Keler, Ph.D., Senior VP & CSO Sam Martin, Senior VP & CFO Anthony S. Marucci, President & CEO Margo Heath-Chiozzi, M.D., Senior VP, Regulatory Affairs
| | Company Description | Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.
In 2007, Celldex merged with AVANT Immunotherapeutics, Inc. to create a diversified biopharmaceutical company with a deep product development pipeline that addresses high-value indications including oncology, infectious and inflammatory diseases.
| |
|
|
|
|
|